Literature DB >> 29665647

miR-362-3p regulates cell proliferation, migration and invasion of trophoblastic cells under hypoxia through targeting Pax3.

Nan Wang1, Yaling Feng2, Jianjuan Xu3, Jinfang Zou3, Minghua Chen3, Yue He3, Huan Liu3, Min Xue1, Yanfang Gu4.   

Abstract

Preeclampsia (PE), a common obstetrical disorder, is one of the leading causes of pregnancy associated death. PE is closely linked with impaired migration and invasion ability of trophoblastic cells. miR-362-3p recently received our particular attention due not only to its aberrant expression in the placentas of patients with PE, but also to its important roles in regulating migration and invasion of various cells. This study was thus conducted to investigate the roles of miR-362-3p in PE and the related mechanism. The expression of miR-362-3p and Pax3 was examined in placentas of patients with PE and in normal placentas. HTR8/SVneo cells were cultured under hypoxia and transfected with miR-362-3p mimics, miR-362-3p inhibitors or Pax3 over-expression vectors. Results showed up-regulation of miR-362-3p but down-regulation of Pax3 in placentas of preeclamptic pregnancies. Luciferase report assay confirmed that Pax3 is a direct target of miR-362-3p. Although Pax3 was predicted to be targeted by miR-30a-3p and miR-181a-5p as well, their expression either had no difference between placentas of PE patients and normal placentas or showed less increment in placentas of PE patients than miR-362-3p. Exposure to hypoxia inhibited cell viability, migration and invasion of HTR8/SVneo cells. Increasing miR-362-3p by the mimics conferred improved effects on the inhibition. However, deletion of miR-362-3p or overexpression of Pax3 abolished the inhibiton. These results suggest that miR-362-3p/Pax3 axis regulates cell viability, migration and invasion of HTR8/SVneo cells under hypoxia. The present study adds to the further understanding of the pathogenesis of PE.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Invasion; Migration; Pax3; Trophoblastic cells; miR-362-3p

Mesh:

Substances:

Year:  2018        PMID: 29665647     DOI: 10.1016/j.biopha.2018.01.089

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

1.  Transcriptomic analysis reveals the role of a peptide derived from CRYAB on the CoCl2-induced hypoxic HL-1 cardiomyocytes.

Authors:  Xiaoshan Hu; Heng Liu; Mengmeng Li; Jingai Zhu; Zhangbin Yu
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

2.  MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation.

Authors:  Abdullah A Assiri; Noha Mourad; Minghai Shao; Patrick Kiel; Wanqing Liu; Todd C Skaar; Brian R Overholser
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

3.  Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.

Authors:  Zhujuan Wang; Xiong Chang; Guannan Zhu; Xiaoting Gao; Luyuan Chang
Journal:  Cell Cycle       Date:  2020-07-14       Impact factor: 4.534

Review 4.  The Role of LIN28-let-7-ARID3B Pathway in Placental Development.

Authors:  Asghar Ali; Gerrit J Bouma; Russell V Anthony; Quinton A Winger
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

5.  Maternal Recognition of Pregnancy in the Horse: Are MicroRNAs the Secret Messengers?

Authors:  Katrien Smits; Yannick Gansemans; Laurentijn Tilleman; Filip Van Nieuwerburgh; Margot Van De Velde; Ilse Gerits; Cyrillus Ververs; Kim Roels; Jan Govaere; Luc Peelman; Dieter Deforce; Ann Van Soom
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

6.  miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia.

Authors:  Heng Zhang; Yue He; Jian-Xia Wang; Ming-Hua Chen; Jian-Juan Xu; Min-Hui Jiang; Ya-Ling Feng; Yan-Fang Gu
Journal:  Redox Biol       Date:  2019-12-09       Impact factor: 11.799

7.  miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer.

Authors:  Shujun Cao; Na Li; Xihong Liao
Journal:  J Ovarian Res       Date:  2021-02-01       Impact factor: 4.234

Review 8.  Roles of noncoding RNAs in preeclampsia.

Authors:  Ningxia Sun; Shiting Qin; Lu Zhang; Shiguo Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

9.  Expression and role of miR-338-3p in peripheral blood and placenta of patients with pregnancy-induced hypertension.

Authors:  Jun Li; Yan Wu; Hui Liu
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

Review 10.  MicroRNAs in Uteroplacental Vascular Dysfunction.

Authors:  Xiang-Qun Hu; Lubo Zhang
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.